.png)
Cancer Diagnostics Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 158 Category: Pharma & Healthcare Report Code : HC095829
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Cancer Diagnostics Market by Type (Laboratory Tests, Endoscopy, Genetic Tests, Imaging, Biopsy, Others) Application (Cervical Cancer, Colorectal Cancer, Skin Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The cancer diagnostics market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Early detection of cancer growth significantly builds the chances for successful treatment. There are two noteworthy parts of early detection of disease that is training to advance early finding and screening. Doctor may utilize at least one ways to deal with analyzing cancer growth that incorporates Physical test, Laboratory tests, Imaging tests, and Biopsy. Cancer Staging tests and strategies may incorporate imaging tests, such as bone outputs or X-beams, to check whether cancer growth has spread to different parts of the body.
Drivers and Restraints
Increasing prevalence of cancer drives the growth of cancer diagnostics market. According to world health organization, Cancer is the second leading cause of death globally and approximately 70% of deaths from cancer occur in low- and middle-income countries. Technological development in effective diagnostic and treatment solutions propels the growth of cancer diagnostics market. Increase in the number of diagnostic and research laboratories fuels the growth of cancer diagnostics market. Increasing investment in research and development activities regarding cancer diagnostics provides beneficial opportunities for the cancer diagnostics market. Huge capital investment may hamper the growth of cancer diagnostics market.
Regional Insights
Among the geographies, North America is expected to dominate the cancer diagnostics market. Advanced healthcare infrastructure, increasing investment in research and development activities in the region contribute to the growth of cancer diagnostics market.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott Laboratories
- Agilent Technologies, Inc.
- GE Healthcare
- F. Hoffmann-La Roche AG
- Toshiba Medical Systems Corporation
- Bio Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers
- Illumina, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Cancer Diagnostics Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Laboratory Tests
o Endoscopy
o Genetic Tests
o Imaging
o Biopsy
o Others
o Cancer Diagnostics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cervical Cancer
o Colorectal Cancer
o Skin Cancer
o Lung Cancer
o Blood Cancer
o Kidney Cancer
o Liver Cancer
o Pancreatic Cancer
o Others
o Cancer Diagnostics Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott Laboratories
o Agilent Technologies, Inc.
o GE Healthcare
o F. Hoffmann-La Roche AG
o Toshiba Medical Systems Corporation
o Bio Rad Laboratories Inc.
o Thermo Fisher Scientific Inc.
o Koninklijke Philips N.V.
o Siemens Healthineers
o Illumina, Inc.
o Cancer Diagnostics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cancer Diagnostics Market , By Country
o U.S. Cancer Diagnostics Market
o Canada Cancer Diagnostics Market
o Mexico Cancer Diagnostics Market
o Europe
§ Europe Cancer Diagnostics Market , By Country
o Germany Cancer Diagnostics Market
o UK Cancer Diagnostics Market
o France Cancer Diagnostics Market
o Russia Cancer Diagnostics Market
o Italy Cancer Diagnostics Market
o Rest of Europe Cancer Diagnostics Market
o Asia-Pacific
§ Asia-Pacific Cancer Diagnostics Market , By Country
o China Cancer Diagnostics Market
o Japan Cancer Diagnostics Market
o South Korea Cancer Diagnostics Market
o India Cancer Diagnostics Market
o Southeast Asia Cancer Diagnostics Market
o Rest of Asia-Pacific Cancer Diagnostics Market
o South America
§ South America Cancer Diagnostics Market , By Country
o Brazil Cancer Diagnostics Market
o Argentina Cancer Diagnostics Market
o Columbia Cancer Diagnostics Market
o Rest of South America Cancer Diagnostics Market
o Middle East and Africa
§ Middle East and Africa Cancer Diagnostics Market , By Country
o Saudi Arabia Cancer Diagnostics Market
o UAE Cancer Diagnostics Market
o Egypt Cancer Diagnostics Market
o Nigeria Cancer Diagnostics Market
o South Africa Cancer Diagnostics Market
o Rest of MEA Cancer Diagnostics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Diagnostics Market, By Type
5.1. Introduction
5.2. Global Cancer Diagnostics Revenue and Market Share by Type (2017-2027)
5.2.1. Global Cancer Diagnostics Revenue and Revenue Share by Type (2017-2027)
5.3. Laboratory Tests
5.3.1. Global Laboratory Tests Revenue and Growth Rate (2017-2027)
5.4. Endoscopy
5.4.1. Global Endoscopy Revenue and Growth Rate (2017-2027)
5.5. Genetic Tests
5.5.1. Global Genetic Tests Revenue and Growth Rate (2017-2027)
5.6. Imaging
5.6.1. Global Imaging Revenue and Growth Rate (2017-2027)
5.7. Biopsy
5.7.1. Global Biopsy Revenue and Growth Rate (2017-2027)
5.8. Others
5.8.1. Global Others Revenue and Growth Rate (2017-2027)
6. Cancer Diagnostics Market, By Application
6.1. Introduction
6.2. Global Cancer Diagnostics Revenue and Market Share by Application (2017-2027)
6.2.1. Global Cancer Diagnostics Revenue and Revenue Share by Application (2017-2027)
6.3. Cervical Cancer
6.3.1. Global Cervical Cancer Revenue and Growth Rate (2017-2027)
6.4. Colorectal Cancer
6.4.1. Global Colorectal Cancer Revenue and Growth Rate (2017-2027)
6.5. Skin Cancer
6.5.1. Global Skin Cancer Revenue and Growth Rate (2017-2027)
6.6. Lung Cancer
6.6.1. Global Lung Cancer Revenue and Growth Rate (2017-2027)
6.7. Blood Cancer
6.7.1. Global Blood Cancer Revenue and Growth Rate (2017-2027)
6.8. Kidney Cancer
6.8.1. Global Kidney Cancer Revenue and Growth Rate (2017-2027)
6.9. Liver Cancer
6.9.1. Global Liver Cancer Revenue and Growth Rate (2017-2027)
6.10. Pancreatic Cancer
6.10.1. Global Pancreatic Cancer Revenue and Growth Rate (2017-2027)
6.11. Others
6.11.1. Global Others Revenue and Growth Rate (2017-2027)
7. Cancer Diagnostics Market, By Region
7.1. Introduction
7.2. Global Cancer Diagnostics Revenue and Market Share by Regions
7.2.1. Global Cancer Diagnostics Revenue by Regions (2017-2027)
7.3. North America Cancer Diagnostics by Countries
7.3.1. North America Cancer Diagnostics Revenue and Growth Rate (2017-2027)
7.3.2. North America Cancer Diagnostics Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Cancer Diagnostics by Countries
7.4.1. Europe Cancer Diagnostics Revenue and Growth Rate (2017-2027)
7.4.2. Europe Cancer Diagnostics Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Cancer Diagnostics by Countries
7.5.1. Asia-Pacific Cancer Diagnostics Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Cancer Diagnostics Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Cancer Diagnostics by Countries
7.6.1. South America Cancer Diagnostics Revenue and Growth Rate (2017-2027)
7.6.2. South America Cancer Diagnostics Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Cancer Diagnostics by Countries
7.7.1. Middle East and Africa Cancer Diagnostics Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Cancer Diagnostics Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Agilent Technologies, Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. GE Healthcare
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. F. Hoffmann-La Roche AG
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Toshiba Medical Systems Corporation
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bio Rad Laboratories Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Thermo Fisher Scientific Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Koninklijke Philips N.V.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Siemens Healthineers
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Illumina, Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Cancer Diagnostics Market Forecast (2017-2027)
9.1. Global Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Cancer Diagnostics Market Forecast by Regions (2017-2027)
9.2.1. North America Cancer Diagnostics Market Forecast (2017-2027)
9.2.1.1. United States Cancer Diagnostics Market Forecast (2017-2027)
9.2.1.2. Canada Cancer Diagnostics Market Forecast (2017-2027)
9.2.1.3. Mexico Cancer Diagnostics Market Forecast (2017-2027)
9.2.2. Europe Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.1. Germany Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.2. France Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.3. UK Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.4. Russia Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.5. Italy Cancer Diagnostics Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Cancer Diagnostics Market Forecast (2017-2027)
9.2.3. Asia-Pacific Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.1. China Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.2. Japan Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.3. Korea Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.4. India Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Cancer Diagnostics Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Cancer Diagnostics Market Forecast (2017-2027)
9.2.4. South America Cancer Diagnostics Market Forecast (2017-2027)
9.2.4.1. Brazil Cancer Diagnostics Market Forecast (2017-2027)
9.2.4.2. Argentina Cancer Diagnostics Market Forecast (2017-2027)
9.2.4.3. Columbia Cancer Diagnostics Market Forecast (2017-2027)
9.2.4.4. Rest of South America Cancer Diagnostics Market Forecast (2017-2027)
9.2.5. Middle East and Africa Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.3. Egypt Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.4. Nigeria Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.5. South Africa Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.6. Turkey Cancer Diagnostics Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Cancer Diagnostics Market Forecast (2017-2027)
9.3. Cancer Diagnostics Market Forecast by Type (2017-2027)
9.3.1. Cancer Diagnostics Forecast by Type (2017-2027)
9.3.2. Cancer Diagnostics Market Share Forecast by Type (2017-2027)
9.4. Cancer Diagnostics Market Forecast by Application (2017-2027)
9.4.1. Cancer Diagnostics Forecast by Application (2017-2027)
9.4.2. Cancer Diagnostics Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Cancer Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Cancer Diagnostics Revenue and Revenue Share by Type (2017-2018)
Figure Global Laboratory Tests Revenue and Growth Rate (2017-2018)
Figure Global Endoscopy Revenue and Growth Rate (2017-2018)
Figure Global Genetic Tests Revenue and Growth Rate (2017-2018)
Figure Global Imaging Revenue and Growth Rate (2017-2018)
Figure Global Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Cancer Diagnostics Revenue and Revenue Share by Application (2017-2018)
Figure Global Cervical Cancer Revenue and Growth Rate (2017-2018)
Figure Global Colorectal Cancer Revenue and Growth Rate (2017-2018)
Figure Global Skin Cancer Revenue and Growth Rate (2017-2018)
Figure Global Lung Cancer Revenue and Growth Rate (2017-2018)
Figure Global Blood Cancer Revenue and Growth Rate (2017-2018)
Figure Global Kidney Cancer Revenue and Growth Rate (2017-2018)
Figure Global Liver Cancer Revenue and Growth Rate (2017-2018)
Figure Global Pancreatic Cancer Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Cancer Diagnostics Revenue by Regions (2017-2018)
Figure North America Cancer Diagnostics Growth Rate (2017-2018)
Figure North America Cancer Diagnostics Revenue and Growth Rate (2017-2018)
Figure North America Cancer Diagnostics by Countries (2017-2018)
Figure North America Cancer Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure United States Cancer Diagnostics Growth Rate (2017-2018)
Figure United States Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Cancer Diagnostics Growth Rate (2017-2018)
Figure Canada Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Cancer Diagnostics Growth Rate (2017-2018)
Figure Mexico Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Cancer Diagnostics Growth Rate (2017-2018)
Figure Europe Cancer Diagnostics Revenue and Growth Rate (2017-2018)
Figure Europe Cancer Diagnostics by Countries (2017-2018)
Figure Europe Cancer Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Cancer Diagnostics Growth Rate (2017-2018)
Figure Germany Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Cancer Diagnostics Growth Rate (2017-2018)
Figure France Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Cancer Diagnostics Growth Rate (2017-2018)
Figure UK Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Cancer Diagnostics Growth Rate (2017-2018)
Figure Russia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Cancer Diagnostics Growth Rate (2017-2018)
Figure Italy Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Cancer Diagnostics Growth Rate (2017-2018)
Figure Rest of Europe Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Diagnostics Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Diagnostics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Cancer Diagnostics by Countries (2017-2018)
Figure Asia-Pacific Cancer Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure China Cancer Diagnostics Growth Rate (2017-2018)
Figure China Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Cancer Diagnostics Growth Rate (2017-2018)
Figure Japan Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Cancer Diagnostics Growth Rate (2017-2018)
Figure Korea Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Cancer Diagnostics Growth Rate (2017-2018)
Figure India Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Cancer Diagnostics Growth Rate (2017-2018)
Figure Southeast Asia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Diagnostics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Cancer Diagnostics Growth Rate (2017-2018)
Figure South America Cancer Diagnostics Revenue and Growth Rate (2017-2018)
Figure South America Cancer Diagnostics by Countries (2017-2018)
Figure South America Cancer Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Cancer Diagnostics Growth Rate (2017-2018)
Figure Brazil Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Cancer Diagnostics Growth Rate (2017-2018)
Figure Argentina Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Cancer Diagnostics Growth Rate (2017-2018)
Figure Columbia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Cancer Diagnostics Growth Rate (2017-2018)
Figure Rest of South America Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Diagnostics Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Diagnostics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Cancer Diagnostics by Countries (2017-2018)
Figure Middle East and Africa Cancer Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Cancer Diagnostics Growth Rate (2017-2018)
Figure Saudi Arabia Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Diagnostics Growth Rate (2017-2018)
Figure United Arab Emirates Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Cancer Diagnostics Growth Rate (2017-2018)
Figure Egypt Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Cancer Diagnostics Growth Rate (2017-2018)
Figure Nigeria Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Cancer Diagnostics Growth Rate (2017-2018)
Figure South Africa Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Cancer Diagnostics Growth Rate (2017-2018)
Figure Turkey Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Diagnostics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Abbott Laboratories Cancer Diagnostics Financial Overview
Table Agilent Technologies, Inc. Cancer Diagnostics Financial Overview
Table GE Healthcare Cancer Diagnostics Financial Overview
Table F. Hoffmann-La Roche AG Cancer Diagnostics Financial Overview
Table Toshiba Medical Systems Corporation Cancer Diagnostics Financial Overview
Table Bio Rad Laboratories Inc. Cancer Diagnostics Financial Overview
Table Thermo Fisher Scientific Inc. Cancer Diagnostics Financial Overview
Table Koninklijke Philips N.V. Cancer Diagnostics Financial Overview
Table Siemens Healthineers Cancer Diagnostics Financial Overview
Table Illumina, Inc. Cancer Diagnostics Financial Overview
Figure Global Cancer Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Cancer Diagnostics Market Forecast by Regions (2018-2025)
Figure North America Cancer Diagnostics Market Forecast (2018-2025)
Figure United States Cancer Diagnostics Market Forecast (2018-2025)
Figure Canada Cancer Diagnostics Market Forecast (2018-2025)
Figure Mexico Cancer Diagnostics Market Forecast (2018-2025)
Figure Europe Cancer Diagnostics Market Forecast (2018-2025)
Figure Germany Cancer Diagnostics Market Forecast (2018-2025)
Figure France Cancer Diagnostics Market Forecast (2018-2025)
Figure UK Cancer Diagnostics Market Forecast (2018-2025)
Figure Russia Cancer Diagnostics Market Forecast (2018-2025)
Figure Italy Cancer Diagnostics Market Forecast (2018-2025)
Figure Rest of Europe Cancer Diagnostics Market Forecast (2018-2025)
Figure Asia-Pacific Cancer Diagnostics Market Forecast (2018-2025)
Figure China Cancer Diagnostics Market Forecast (2018-2025)
Figure Japan Cancer Diagnostics Market Forecast (2018-2025)
Figure Korea Cancer Diagnostics Market Forecast (2018-2025)
Figure India Cancer Diagnostics Market Forecast (2018-2025)
Figure Southeast Asia Cancer Diagnostics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Cancer Diagnostics Market Forecast (2018-2025)
Figure South America Cancer Diagnostics Market Forecast (2018-2025)
Figure Brazil Cancer Diagnostics Market Forecast (2018-2025)
Figure Argentina Cancer Diagnostics Market Forecast (2018-2025)
Figure Columbia Cancer Diagnostics Market Forecast (2018-2025)
Figure Rest of South America Cancer Diagnostics Market Forecast (2018-2025)
Figure Middle East and Africa Cancer Diagnostics Market Forecast (2018-2025)
Figure Saudi Arabia Cancer Diagnostics Market Forecast (2018-2025)
Figure United Arab Emirates Cancer Diagnostics Market Forecast (2018-2025)
Figure Egypt Cancer Diagnostics Market Forecast (2018-2025)
Figure Nigeria Cancer Diagnostics Market Forecast (2018-2025)
Figure South Africa Cancer Diagnostics Market Forecast (2018-2025)
Figure Turkey Cancer Diagnostics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Cancer Diagnostics Market Forecast (2018-2025)
Figure Global Cancer Diagnostics Forecast by Type (2018-2025)
Figure Global Cancer Diagnostics Market Share Forecast by Type (2018-2025)
Figure Global Cancer Diagnostics Forecast by Type (2018-2025)
Figure Global Cancer Diagnostics Forecast by Application (2018-2025)
Figure Global Cancer Diagnostics Market Share Forecast by Application (2018-2025)
Figure Global Cancer Diagnostics Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|